gondii</i>-free lambs.<h4>Conclusion</h4>This study highlights the potential utility of BKI-1748 for prenatal treatment of human congenital toxoplasmosis, in which IgM seroconversion prompts the need for intervention. This evidence concerns the gene CD40LG and congenital toxoplasmosis.